Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CTKB
CYTEK BIOSCIENCES, INC.
NASDAQ
$4.68
▲ UP 1.30% (0.06)

KEY STATISTICS

Market Cap$604.39 M
52w High$6.18
52w Low$3.28
Dividend Yield—
Frequency—
P/E-24.79
Volume796.31K
Shares Out.129.14M

COMPANY

LEADERSHIP

Wenbin Jiang
CHIEF EXECUTIVE
Wenbin Jiang

COMPENSATION 2026

Salary$620,000
Stock Awards$2,000,000
Incentive Plan Pay$485,211
All Other Comp.$14,850
Total$5,120,061

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 23, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
682

PRICE TARGET

Target High$5.00
Target Low$4.75
Target Median$4.88
Target Consensus$4.88

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$52.95M
NOV
4
WED

PRICE

$4.68 ▲ UP 1.30% (+$0.06)
$4.50$4.58$4.659:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.68

About Cytek Biosciences, Inc.

https://cytekbio.com ↗

Cytek Biosciences develops advanced spectrum flow cytometry systems, reagents, and software for cell analysis, serving biomedical research, clinical, and biopharma markets worldwide.

INDUSTRY

Medical - Devices

A PRODUCT CYTEK BIOSCIENCES, INC. IS KNOWN FOR

Cytek Aurora™ Evo system
Cytek Aurora™ Evo system

The Cytek Aurora™ Evo is a high-throughput, automated spectral flow cytometer built on the flagship Aurora, offering advanced multicolor analysis with improved performance, efficiency, and ease of use for complex cell research.

COMPETITORS

COMPETITOR
A COMPARE
BDX COMPARE
BIO COMPARE
LAB COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Service$43.11M $0 ▼$46.27M ▲$46.3M ▲
Product$38.11M $46.59M ▲$28.78M ▼$32.56M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$27.2M $25.62M ▼$24.39M ▼$28.22M ▲
EMEA$12.38M $19.62M ▲$10.77M ▼$11.3M ▲
Asia Pacific$11.14M $13.18M ▲$7.75M ▼$7.92M ▲
Other$1.56M $3.72M ▲$1.23M ▼$701K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
79
LISTED HERE
13
RANKED BY POSITION SIZE
VTS.AX
0.00% · 3.5M
IWM
0.02% · 3.1M
FESM
0.04% · 566.0K
SCHA
0.01% · 525.1K
DFAC
0.00% · 372.8K
AVSC
0.04% · 254.4K
ZPRR.DE
0.02% · 211.8K
GSSC
0.08% · 186.5K
PRFZ
0.02% · 123.7K
XRSU.L
0.02% · 105.0K
RSSL
0.02% · 57.8K
FSML
0.09% · 30.5K
URTY
0.01% · 4.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
70.26%
HOLDERS
210
TOP 12 OF 210 · RANKED BY POSITION SIZE
Blackrock, Inc.
17.2M sh · $86.72M
Blackrock Inc.
17.1M sh · $95.25M
Millennium Management LLC
9.3M sh · $41.37M
Boston Partners
7.7M sh · $33.94M
Vanguard Group Inc
7.5M sh · $37.75M
Topline Capital Management, LLC
7.4M sh · $37.58M
Hhlr Advisors, Ltd.
6.7M sh · $29.49M
Brown Capital Management LLC
5.0M sh · $17.2M
State Street Corp
4.1M sh · $20.94M
Dimensional Fund Advisors LP
3.2M sh · $11.17M
Geode Capital Management, LLC
3.1M sh · $13.56M
Wellington Management Group Llp
2.5M sh · $8.82M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR
MUIR GLENN P
Sale · 3.1K shares
2026-08-18
★
DIRECTOR
MUIR GLENN P
Purchase · 3.1K shares
2026-08-18
★
DIRECTOR
Chin Richard
Purchase · 6.1K shares
2026-08-18
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Jiang Wenbin
Purchase · 29.0K shares
2026-08-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 2
EQUAL WEIGHT 1
BUY 1
4 GRADES IN THE LAST 12 MONTHS
Stephens & Co. OVERWEIGHT Morgan Stanley EQUAL WEIGHT TD Cowen BUY Piper Sandler OVERWEIGHT

SECTORS PEERS

PEERPRICE
CBLL$23.73COMPARE
VREX$18.50COMPARE
ANGO$15.85COMPARE
KIDS$23.65COMPARE
CLPT$15.55COMPARE
TMCI$4.65COMPARE
LAB$0.64COMPARE
ORGO$1.74COMPARE